Literature DB >> 7497155

Glaucoma screening.

R P Wormald1, A Rauf.   

Abstract

National screening programmes probably cannot be justified at present given difficulties with test validity, manpower, and some doubts about the natural history of the disease. The opportunity cost could be prohibitive, especially when resources are badly needed in other areas of ophthalmology, such as cataract programmes, diabetic retinopathy, and low vision services. The situation could change with an improved test with greater validity for primary screening and such tests are currently under investigation. The results of these investigations will not be available for at least three years. Screening for eye disease at the primary care level begs questions about manpower which need to be answered not just for glaucoma screening but also for detection of diabetic retinopathy and visual impairment in the elderly. A new cadre of ophthalmic paramedics as is already in wide use in some developing countries, who amalgamate the skills of optometrist, orthoptist, and eye trained nurse, is an interesting possibility. Meanwhile, much has to be done to improve current case finding with agreed standards of examination and referral criteria and special facilities available for those at increased risk.

Entities:  

Mesh:

Year:  1995        PMID: 7497155     DOI: 10.1177/096914139500200212

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  7 in total

1.  Agreement between optometrists and ophthalmologists on clinical management decisions for patients with glaucoma.

Authors:  M J Banes; L E Culham; C Bunce; W Xing; A Viswanathan; D Garway-Heath
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

2.  Evaluation of the effectiveness of ophthalmic assistants as screeners for glaucoma in North India.

Authors:  S K Sinha; N Astbury
Journal:  Eye (Lond)       Date:  2011-07-01       Impact factor: 3.775

Review 3.  Screening for glaucoma. Why is the disease underdetected?

Authors:  M W Tuck; R P Crick
Journal:  Drugs Aging       Date:  1997-01       Impact factor: 3.923

4.  Current estimates of blindness in India.

Authors:  G Venkata S Murthy; S K Gupta; D Bachani; R Jose; N John
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

5.  [Glaucoma and ocular hypertension in primary care].

Authors:  J Jaén Díaz; I Sanz Alcolea; F López De Castro; T Pérez Martínez; P Ortega Campos; R Corral Morales
Journal:  Aten Primaria       Date:  2001-06-15       Impact factor: 1.137

6.  Deprivation and late presentation of glaucoma: case-control study.

Authors:  S Fraser; C Bunce; R Wormald; E Brunner
Journal:  BMJ       Date:  2001-03-17

7.  Visual impairment and blindness in Europe and their prevention.

Authors:  I Kocur; S Resnikoff
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.